Aramsangtienchai Pornpun, Spiegelman Nicole A, He Bin, Miller Seth P, Dai Lunzhi, Zhao Yingming, Lin Hening
Department of Chemistry and Chemical Biology, Cornell University , Ithaca, New York 14853, United States.
Ben May Department of Cancer Research, The University of Chicago , Chicago, Illinois 60637, United States.
ACS Chem Biol. 2016 Oct 21;11(10):2685-2692. doi: 10.1021/acschembio.6b00396. Epub 2016 Aug 5.
The histone deacetylase (HDAC) family regulates many biological pathways through the deacetylation of lysine residues on histone and nonhistone proteins. Mammals have 18 HDACs that are classified into four classes. Class I, II, and IV are zinc-dependent, while class III is nicotinamide adenine dinucleotide (NAD)-dependent lysine deacetylase or sirtuins. HDAC8, a class I HDAC family member, has been shown to have low deacetylation activity compared to other HDACs in vitro. Recent studies showed that several sirtuins, with low deacetylase activities, can actually hydrolyze other acyl lysine modifications more efficiently. Inspired by this, we tested the activity of HDAC8 using a variety of different acyl lysine peptides. Screening a panel of peptides with different acyl lysine modifications, we found that HDAC8 can catalyze the removal of acyl groups with 2-16 carbons from lysine 9 of the histone H3 peptide (H3K9). Interestingly, the catalytic efficiencies (k/K) of HDAC8 on octanoyl, dodecanoyl, and myristoyl lysine are several-fold better than that on acetyl lysine. The increased catalytic efficiencies of HDAC8 on larger fatty acyl groups are due to the much lower K values. T-cell leukemia Jurkat cells treated with a HDAC8 specific inhibitor, PCI-34051, exhibited an increase in global fatty acylation compared to control treatment. Thus, the de-fatty-acylation activity of HDAC8 is likely physiologically relevant. This is the first report of a zinc-dependent HDAC with de-fatty-acylation activity, and identification of HDAC8 de-fatty-acylation targets will help to further understand the function of HDAC8 and protein lysine fatty acylation.
组蛋白去乙酰化酶(HDAC)家族通过对组蛋白和非组蛋白上赖氨酸残基的去乙酰化作用来调节多种生物学途径。哺乳动物有18种HDAC,分为四类。I类、II类和IV类是锌依赖性的,而III类是烟酰胺腺嘌呤二核苷酸(NAD)依赖性赖氨酸去乙酰化酶或沉默调节蛋白。HDAC8是I类HDAC家族成员,体外实验表明,与其他HDAC相比,它的去乙酰化活性较低。最近的研究表明,几种去乙酰化酶活性较低的沉默调节蛋白实际上可以更有效地水解其他酰基赖氨酸修饰。受此启发,我们使用多种不同的酰基赖氨酸肽测试了HDAC8的活性。通过筛选一组具有不同酰基赖氨酸修饰的肽,我们发现HDAC8可以催化从组蛋白H3肽(H3K9)的赖氨酸9上去除含2至16个碳的酰基。有趣的是,HDAC8对辛酰基、十二烷酰基和肉豆蔻酰基赖氨酸的催化效率(k/K)比对乙酰赖氨酸的催化效率高几倍。HDAC8对较大脂肪酰基的催化效率增加是由于K值低得多。用HDAC8特异性抑制剂PCI-34051处理的T细胞白血病Jurkat细胞与对照处理相比,整体脂肪酰化增加。因此,HDAC8的去脂肪酰化活性可能具有生理相关性。这是关于具有去脂肪酰化活性的锌依赖性HDAC的首次报道,鉴定HDAC8的去脂肪酰化靶点将有助于进一步了解HDAC8的功能和蛋白质赖氨酸脂肪酰化。